Soluble FcgammaRIIIa as a marker for rheumatoid arthritis: the use of genetics in selected populations to study pathogenetic pathways.
Huizinga
Tom W J
TW
Ioan-Facsinay
Andreea
A
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D011379:Prognosis; D017452:Receptors, IgG / Q000235:genetics*; D012217:Rheumatoid Factor / Q000235:genetics; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012995:Solubility
D005819:Genetic Markers; D006684:HLA-DR Antigens; D017452:Receptors, IgG; D012217:Rheumatoid Factor